Annexon Biosciences GAAP EPS of -$0.34 beats by $0.03

* Annexon Biosciences press release [https://seekingalpha.com/pr/20201908-annexon-reports-second-quarter-2025-financial-results-portfolio-progress-and-key-anticipated] (NASDAQ:ANNX [https://seekingalpha.com/symbol/ANNX]): Q2 GAAP EPS of -$0.34 beats by $0.03.
* Cash and cash equivalents and short-term investments were $227.0 million as of June 30, 2025.

MORE ON ANNEXON BIOSCIENCES

* Annexon: Lead GBS Therapy Stokes Near-Term Potential [https://seekingalpha.com/article/4801121-annexon-lead-gbs-therapy-stokes-near-term-potential]
* Seeking Alpha’s Quant Rating on Annexon Biosciences [https://seekingalpha.com/symbol/ANNX/ratings/quant-ratings]
* Historical earnings data for Annexon Biosciences [https://seekingalpha.com/symbol/ANNX/earnings]
* Financial information for Annexon Biosciences [https://seekingalpha.com/symbol/ANNX/income-statement]